Product Name: Human TFPI Antibody (Befovacimab, Research Use)
Catalog Number: NBR-0520
Target Name: TFPI
Trade Name: Befovacimab
Antibody Drug Description: Befovacimab (formerly BAY 1093884) is a fully human monoclonal antibody able to bind to tissue factor pathway inhibitor (TFPI) and developed as a non-replacement therapy for individuals with haemophilia A/B, with or without inhibitors. Appearance: Transparent Liquid
Molecular Weight: ~150kDa
CAS：N/A
Solubility: Water; PBS, TBS Buffer etc.
Expression System: CHO Expressed
Isotype of Ab: Ab. Isotype - IgG

  Gene Name:  TFPI
Synonyms: EPI; LACI; TFI; TFPI1
Target Description: Inhibits factor X (X(a)) directly and, in a Xa-dependent way, inhibits VIIa/tissue factor activity, presumably by forming a quaternary Xa/LACI/VIIa/TF complex.
Ensembl: ENSG00000003436
Uniprot:  P10646